Understanding and overcoming acquired resistance to third generation EGFR inhibitors

Lecture | October 24, 2017/10:00a.m. | Conference Hall on the 7th Floor in the Polytechnic Building

peaker: Professor Sun Shi-yong, Emory University Cancer Center

Host: Professor Shi Zhi

ABOUT SUN SHI-YONG

Professor Sun Shi-yong is a tenured professor at the Cancer Center, Hematology and Oncology schools of Emory University. His team has achieved a lot in identifying and developing innovative and effective anticancer drugs or making relative medical programs, especially in finding the spreading direction and living time of certain drugs in tumor cells. Professor Sun Shiyong has published over 100 papers in SCI papers and won several awards in the field with one paper most cited to over 1400 times. Besides, he has been the leader of more than 10 projects, including the United States NIH / NCI R01, P01, SPORE and rewarded as one of the most outstanding cancer researchers in the United States Georgia Cancer Research. He is also a member of over 50 international SCI journals and the assessment expert in Cancer Research UK and Health Research Board's Post-Doctoral Research.